Vaccines were originally developed to prevent potentially deadly childhood diseases, but during the 21st century attention broadened to include prevention of infection in all stages of life. Prevention and treatment of bacterial infections are two of the biggest public health challenges of the 21st century. A crisis threatens to arise as the ageing of the population and the associated increase in cases of life-threatening bacteraemia and healthcare-associated infection coincides with an increase in antimicrobial resistance.